About this trial
Brief Title: Predicting Hypothermia in Gynecological Laparoscopic Surgery Using Machine Learning
Brief Summary: This study aims to develop and validate a machine learning model for predicting intraoperative hypothermia (IOH) in patients undergoing gynecological laparoscopic surgery based on preoperative clinical indicators. This prospective, multicenter case-control study will enroll female patients aged 18 years and older who are scheduled for laparoscopic surgery across multiple hospitals from 2026 to 2027. The primary objective is to identify high-risk patients who may experience IOH, defined as a core temperature below 36.0°C during surgery.
Participants will be classified into two groups: the IOH group, consisting of patients who experience hypothermia, and the normal temperature group, comprising patients who maintain a core temperature of 36.0°C or higher. Data collection will include demographics, comorbidities, surgical details, anesthesia information, and preoperative laboratory results.
The primary outcome measure will be the area under the curve (AUC) of the model, assessing its predictive performance at various thresholds. Secondary outcomes will include sensitivity, positive predictive value, negative predictive value, and F1 score. The study hypothesizes that the developed machine learning model will significantly improve the accuracy and timeliness of predicting IOH, thereby enhancing patient safety during surgery and postoperative recovery. This research is expected to inform clinical practices related to preventative warming strategies, ultimately improving patient outcomes in gynecological laparoscopic surgery.
Eligibility criteria
Qualifiers
Female patients aged 18 years or older.
Patients scheduled for laparoscopic surgery.
Disqualifiers
Preoperative body temperature exceeding 37.5°C or below 36.0°C.
History of hypothyroidism or hyperthyroidism.
Patients with thermoregulatory dysfunction, such as severe infection or central nervous system disorders.
Patients who refuse to sign the informed consent form.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Chengdu Jinjiang Maternity and Child Health Hospital
Lead sponsor
Sichuan Jinxin Xinan Women & Children's Hospital
Collaborator
People ' s Hospital of Dayi County
Collaborator
Medical Center Hospital of QiongLai City
Collaborator